Literature DB >> 17907380

2'-C-Methyl branched pyrimidine ribonucleoside analogues: potent inhibitors of RNA virus replication.

Samira Benzaria1, Dorothée Bardiot, Tony Bouisset, Clément Counor, Céline Rabeson, Claire Pierra, Richard Storer, Anna Giulia Loi, Alessandra Cadeddu, Massimo Mura, Chiara Musiu, Michel Liuzzi, Roberta Loddo, Svetlana Bergelson, Vadim Bichko, Edward Bridges, Erika Cretton-Scott, John Mao, Jean-Pierre Sommadossi, Maria Seifer, David Standring, Michele Tausek, Gilles Gosselin, Paolo La Colla.   

Abstract

RNA viruses are the agents of numerous widespread and often severe diseases. Their unique RNA-dependent RNA polymerase (RDRP) is essential for replication and, thus, constitutes a valid target for the development of selective chemotherapeutic agents. In this regard, we have investigated sugar-modified ribonucleoside analogues as potential inhibitors of the RDRP. Title compounds retain 'natural' pyrimidine bases, but possess a beta-methyl substituent at the 2'-position of the D- or L-ribose moiety. Evaluation against a broad range of RNA viruses, either single-stranded positive (ssRNA+), single-stranded negative (ssRNA-) or double-stranded (dsRNA), revealed potent activities for D-2'-C-methyl-cytidine and -uridine against ssRNA+, and dsRNA viruses. None of the L-enantiomers were active. Moreover, the 5'-triphosphates of the active D-enantiomers were found to inhibit the bovine virus diarrhoea virus polymerase. Thus, the 2'-methyl branching of natural pyrimidine ribonucleosides transforms physiological molecules into potent, broad-spectrum antiviral agents that merit further development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17907380     DOI: 10.1177/095632020701800406

Source DB:  PubMed          Journal:  Antivir Chem Chemother        ISSN: 0956-3202


  6 in total

Review 1.  Advances in nucleoside monophosphate prodrugs as anti-HCV agents.

Authors:  Drew R Bobeck; Raymond F Schinazi; Steven J Coats
Journal:  Antivir Ther       Date:  2010

2.  Anti-hepatitis C virus activity of novel beta-d-2'-C-methyl-4'-azido pyrimidine nucleoside phosphoramidate prodrugs.

Authors:  Ramu Rondla; Steven J Coats; Tamara R McBrayer; Jason Grier; Melissa Johns; Phillip M Tharnish; Tony Whitaker; Longhu Zhou; Raymond F Schinazi
Journal:  Antivir Chem Chemother       Date:  2009-10-19

3.  Antiviral activity of nucleoside analogues against norovirus.

Authors:  Verónica P Costantini; Tony Whitaker; Leslie Barclay; David Lee; Tamara R McBrayer; Raymond F Schinazi; Jan Vinjé
Journal:  Antivir Ther       Date:  2012-08-14

Review 4.  Nucleosides for the treatment of respiratory RNA virus infections.

Authors:  Paul C Jordan; Sarah K Stevens; Jerome Deval
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec

5.  The Adenosine Analogue NITD008 has Potent Antiviral Activity against Human and Animal Caliciviruses.

Authors:  Daniel Enosi Tuipulotu; Tulio M Fumian; Natalie E Netzler; Jason M Mackenzie; Peter A White
Journal:  Viruses       Date:  2019-05-30       Impact factor: 5.048

Review 6.  Inhibition of viral RNA polymerases by nucleoside and nucleotide analogs: therapeutic applications against positive-strand RNA viruses beyond hepatitis C virus.

Authors:  Jerome Deval; Julian A Symons; Leo Beigelman
Journal:  Curr Opin Virol       Date:  2014-09-17       Impact factor: 7.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.